Arrowhead Research | ARWR - Capitale Ordinario

Prezzo Delle Azioni
73.91
Cambio Giornaliero
-0.49 -0.66%
Mensile
21.62%
Annuale
457.81%
Q2 Previsione
72.33




Capitale Ordinario Cambiamento Data
Agios Pharmaceuticals USD 58.45M 169K 2025-12
Alnylam Pharmaceuticals USD 132.38M 585K 2025-12
Anika Therapeutics USD 13.89M 532K 2025-12
Arrowhead Research USD 135.7M 2.44M 2025-09
Heron Therapeutics USD 188.31M 4.99M 2025-12
Incyte USD 198.46M 2.33M 2025-12
Ionis Pharmaceuticals USD 161.97M 836K 2025-12
Ligand Pharmaceuticals USD 19.66M 19.64M 2025-09
Merck USD 2.49B 15.79M 2025-09
Moderna USD 391M 2M 2025-09
Nektar Therapeutics USD 20.38M 20.36M 2025-12
Novartis USD 1.91B 10.64M 2025-12
Sarepta Therapeutics USD 104.96M 196K 2025-12
TG Therapeutics USD 155.21M 2.81M 2025-09
Ultragenyx Pharmaceutical USD 96.44M 88K 2025-09
Vertex Pharmaceuticals USD 254M 0 2025-12
Xencor USD 71.87M 529K 2025-12